awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40058585-A0C122BA-19D2-4566-9652-0BD24A802C91
Q40058585-A0C122BA-19D2-4566-9652-0BD24A802C91
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40058585-A0C122BA-19D2-4566-9652-0BD24A802C91
Safety issues associated with using medication to treat overactive bladder.
P2860
Q40058585-A0C122BA-19D2-4566-9652-0BD24A802C91
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40058585-A0C122BA-19D2-4566-9652-0BD24A802C91
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4710ca21aee50a46cb7f0a165531e36a1db712a0
P2860
Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder.